{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T03:51:48Z","timestamp":1793245908189,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T00:00:00Z","timestamp":1761350400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Anhui Province Natural Science Foundation youth project","award":["1808085QH274"],"award-info":[{"award-number":["1808085QH274"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"DOI":"10.1007\/s00018-025-05855-x","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T09:43:01Z","timestamp":1761385381000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Mechanism of LncRNA NORAD regulating ferroptosis in endometrial cancer cells by modifying GPX4 through FTO-mediated m6A methylation"],"prefix":"10.1007","volume":"82","author":[{"given":"Jieqi","family":"Ke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianjiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9650-1604","authenticated-orcid":false,"given":"Dabao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,25]]},"reference":[{"issue":"6","key":"5855_CR1","volume":"1878","author":"D Capoferri","year":"2023","unstructured":"Capoferri D, Bignotti E, Ravaggi A, Mitola S, Romani C (2023) Finding the junction between claudins and endometrial carcinoma. Biochimica et Biophysica Acta (BBA) 1878(6):189019","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"3","key":"5855_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s12032-023-01956-4","volume":"40","author":"Y Shen","year":"2023","unstructured":"Shen Y, Shi R, Zhao R, Wang H (2023) Clinical application of liquid biopsy in endometrial carcinoma. Med Oncol 40(3):92","journal-title":"Med Oncol"},{"issue":"4","key":"5855_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/path.5608","volume":"253","author":"J Huvila","year":"2021","unstructured":"Huvila J, Pors J, Thompson EF, Gilks CB (2021) Endometrial carcinoma: molecular subtypes, precursors and the role of pathology in early diagnosis. J Pathol 253(4):355\u2013365","journal-title":"J Pathol"},{"issue":"3","key":"5855_CR4","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1007\/s11033-021-06247-7","volume":"48","author":"R Liu","year":"2021","unstructured":"Liu R, Wang X, Shen Y, He A (2021) Long non-coding RNA-based glycolysis-targeted cancer therapy: feasibility, progression and limitations. Mol Biol Rep 48(3):2713\u20132727","journal-title":"Mol Biol Rep"},{"issue":"15","key":"5855_CR5","doi-asserted-by":"publisher","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","volume":"77","author":"A Bhan","year":"2017","unstructured":"Bhan A, Soleimani M, Mandal SS (2017) Long noncoding RNA and cancer: a new paradigm. Cancer Res 77(15):3965\u20133981","journal-title":"Cancer Res"},{"issue":"6","key":"5855_CR6","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41419-020-2674-y","volume":"11","author":"T Han","year":"2020","unstructured":"Han T, Wu Y, Hu X, Chen Y, Jia W, He Q et al (2020) NORAD orchestrates endometrial cancer progression by sequestering FUBP1 nuclear localization to promote cell apoptosis. Cell Death Dis 11(6):473","journal-title":"Cell Death Dis"},{"issue":"1","key":"5855_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28990-6","volume":"13","author":"G Li","year":"2022","unstructured":"Li G, Ma L, He S, Luo R, Wang B, Zhang W et al (2022) WTAP-mediated m(6)a modification of LncRNA NORAD promotes intervertebral disc degeneration. Nat Commun 13(1):1469","journal-title":"Nat Commun"},{"issue":"1","key":"5855_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12943-021-01356-0","volume":"20","author":"MB Uddin","year":"2021","unstructured":"Uddin MB, Wang Z, Yang C (2021) The m(6)A RNA methylation regulates oncogenic signaling pathways driving cell malignant transformation and carcinogenesis. Mol Cancer 20(1):61","journal-title":"Mol Cancer"},{"issue":"3","key":"5855_CR9","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W, Qin X, Shi H, Wu H et al (2018) Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol 20(3):285\u2013295","journal-title":"Nat Cell Biol"},{"issue":"1","key":"5855_CR10","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s12943-019-1106-z","volume":"18","author":"T Lan","year":"2019","unstructured":"Lan T, Li H, Zhang D, Xu L, Liu H, Hao X et al (2019) KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3. Mol Cancer 18(1):186","journal-title":"Mol Cancer"},{"issue":"7","key":"5855_CR11","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1136\/gutjnl-2019-319639","volume":"69","author":"Q Wang","year":"2020","unstructured":"Wang Q, Chen C, Ding Q, Zhao Y, Wang Z, Chen J et al (2020) METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut 69(7):1193\u20131205","journal-title":"Gut"},{"key":"5855_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073800","author":"SK Azzam","year":"2022","unstructured":"Azzam SK, Alsafar H, Sajini AA (2022) FTO m6A demethylase in obesity and cancer: implications and underlying molecular mechanisms. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23073800","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5855_CR13","first-page":"1059","volume":"45","author":"B Qin","year":"2021","unstructured":"Qin B, Dong M, Wang Z, Wan J, Xie Y, Jiao Y et al (2021) Long non\u2013coding RNA CASC15 facilitates esophageal squamous cell carcinoma tumorigenesis via decreasing SIM2 stability via FTO\u2013mediated demethylation. Oncol Rep 45(3):1059\u20131071","journal-title":"Oncol Rep"},{"key":"5855_CR14","doi-asserted-by":"publisher","first-page":"101034","DOI":"10.1016\/j.neo.2024.101034","volume":"56","author":"J Mi","year":"2024","unstructured":"Mi J, Wang Y, He S, Qin X, Li Z, Zhang T et al (2024) LncRNA HOTAIRM1 promotes radioresistance in nasopharyngeal carcinoma by modulating FTO acetylation-dependent alternative splicing of CD44. Neoplasia 56:101034","journal-title":"Neoplasia"},{"issue":"9","key":"5855_CR15","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/cr.2017.99","volume":"27","author":"PJ Hsu","year":"2017","unstructured":"Hsu PJ, Zhu Y, Ma H, Guo Y, Shi X, Liu Y et al (2017) Ythdc2 is an N(6)-methyladenosine binding protein that regulates mammalian spermatogenesis. Cell Res 27(9):1115\u20131127","journal-title":"Cell Res"},{"issue":"9","key":"5855_CR16","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1080\/15476286.2020.1841458","volume":"18","author":"L Zhang","year":"2021","unstructured":"Zhang L, Wan Y, Zhang Z, Jiang Y, Lang J, Cheng W et al (2021) FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway. RNA Biol 18(9):1265\u20131278","journal-title":"RNA Biol"},{"issue":"2","key":"5855_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2298-2","volume":"11","author":"J Li","year":"2020","unstructured":"Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao N et al (2020) Ferroptosis: past, present and future. Cell Death Dis 11(2):88","journal-title":"Cell Death Dis"},{"issue":"5","key":"5855_CR18","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060\u20131072","journal-title":"Cell"},{"issue":"12","key":"5855_CR19","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1038\/cdd.2017.149","volume":"24","author":"HO Fearnhead","year":"2017","unstructured":"Fearnhead HO, Vandenabeele P, Vanden Berghe T (2017) How do we fit ferroptosis in the family of regulated cell death? Cell Death Differ 24(12):1991\u20131998","journal-title":"Cell Death Differ"},{"issue":"12","key":"5855_CR20","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/ncb3064","volume":"16","author":"JP Friedmann Angeli","year":"2014","unstructured":"Friedmann Angeli JP, Schneider M, Proneth B, Tyurina YY, Tyurin VA, Hammond VJ et al (2014) Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol 16(12):1180\u20131191","journal-title":"Nat Cell Biol"},{"issue":"1\u20132","key":"5855_CR21","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang WS, SriRamaratnam R, Welsch ME, Shimada K, Skouta R, Viswanathan VS et al (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156(1\u20132):317\u2013331","journal-title":"Cell"},{"issue":"1","key":"5855_CR22","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1186\/s12885-022-09986-3","volume":"22","author":"S Wei","year":"2022","unstructured":"Wei S, Yu Z, Shi R, An L, Zhang Q, Zhang Q et al (2022) Gpx4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1. BMC Cancer 22(1):881","journal-title":"BMC Cancer"},{"issue":"1","key":"5855_CR23","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41420-023-01746-x","volume":"9","author":"G Zhang","year":"2023","unstructured":"Zhang G, Mi W, Wang C, Li J, Zhang Y, Liu N et al (2023) Targeting AKT induced ferroptosis through FTO\/YTHDF2-dependent GPX4 m6a methylation up-regulating and degradating in colorectal cancer. Cell Death Discov 9(1):457","journal-title":"Cell Death Discov"},{"issue":"12","key":"5855_CR24","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1007\/s11010-024-04930-4","volume":"479","author":"M Liao","year":"2024","unstructured":"Liao M, Zou S, Wu J, Bai J, Liu Y, Zhi K et al (2024) METTL3-mediated m6A modification of NORAD inhibits the ferroptosis of vascular smooth muscle cells to attenuate the aortic dissection progression in an YTHDF2-dependent manner. Mol Cell Biochem 479(12):3471\u20133487","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"5855_CR25","doi-asserted-by":"publisher","first-page":"24223","DOI":"10.1038\/s41598-024-76243-x","volume":"14","author":"T He","year":"2024","unstructured":"He T, Pu J, Ge H, Liu T, Lv X, Zhang Y et al (2024) Elevated circulating lncRNA NORAD fosters endothelial cell growth and averts ferroptosis by modulating the miR-106a\/CCND1 axis in CAD patients. Sci Rep 14(1):24223","journal-title":"Sci Rep"},{"issue":"1","key":"5855_CR26","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1515\/med-2022-0538","volume":"17","author":"W Mao","year":"2022","unstructured":"Mao W, Wang S, Chen R, He Y, Lu R, Zheng M (2022) LncRNA NORAD promotes lung cancer progression by competitively binding to miR-28-3p with E2F2. Open Med (Wars) 17(1):1538\u20131549","journal-title":"Open Med (Wars)"},{"issue":"1","key":"5855_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12905-023-02857-4","volume":"24","author":"HH Lin","year":"2024","unstructured":"Lin HH, Zeng WH, Yang HK, Huang LS, Pan R, Lei NX (2024) Fanconi anemia complementation group D2 promotes sensitivity of endometrial cancer cells to chemotherapeutic agents by inhibiting the ferroptosis pathway. BMC Womens Health 24(1):41","journal-title":"BMC Womens Health"},{"key":"5855_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121753","volume":"325","author":"H Murakami","year":"2023","unstructured":"Murakami H, Hayashi M, Terada S, Ohmichi M (2023) Medroxyprogesterone acetate-resistant endometrial cancer cells are susceptible to ferroptosis inducers. Life Sci 325:121753","journal-title":"Life Sci"},{"issue":"11","key":"5855_CR29","doi-asserted-by":"publisher","first-page":"638","DOI":"10.3858\/emm.2011.43.11.072","volume":"43","author":"XT Wang","year":"2011","unstructured":"Wang XT, Xie YB, Xiao Q (2011) Lentivirus-mediated RNA interference targeting E2F-1 inhibits human gastric cancer MGC-803 cell growth in vivo. Exp Mol Med 43(11):638\u2013645","journal-title":"Exp Mol Med"},{"issue":"8","key":"5855_CR30","doi-asserted-by":"publisher","first-page":"8961","DOI":"10.1096\/fj.201900077R","volume":"33","author":"M Guerrero-Hue","year":"2019","unstructured":"Guerrero-Hue M, Garcia-Caballero C, Palomino-Antolin A, Rubio-Navarro A, Vazquez-Carballo C, Herencia C et al (2019) Curcumin reduces renal damage associated with rhabdomyolysis by decreasing ferroptosis-mediated cell death. FASEB J 33(8):8961\u20138975","journal-title":"FASEB J"},{"issue":"6","key":"5855_CR31","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.tjog.2022.09.001","volume":"61","author":"PH Wang","year":"2022","unstructured":"Wang PH, Yang ST, Liu CH, Chang WH, Lee FK, Lee WL (2022) Endometrial cancer: part I. Basic concept. Taiwan J Obstet Gynecol 61(6):951\u2013959","journal-title":"Taiwan J Obstet Gynecol"},{"issue":"1","key":"5855_CR32","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/GCO.0000000000000338","volume":"29","author":"YC Lee","year":"2017","unstructured":"Lee YC, Lheureux S, Oza AM (2017) Treatment strategies for endometrial cancer: current practice and perspective. Curr Opin Obstet Gynecol 29(1):47\u201358","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"4","key":"5855_CR33","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.gendis.2020.04.009","volume":"8","author":"A Ahadi","year":"2021","unstructured":"Ahadi A (2021) Functional roles of LncRNAs in the pathogenesis and progression of cancer. Genes Dis 8(4):424\u2013437","journal-title":"Genes Dis"},{"key":"5855_CR34","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.biopha.2018.07.101","volume":"106","author":"H Huo","year":"2018","unstructured":"Huo H, Tian J, Wang R, Li Y, Qu C, Wang N (2018) Long non-coding RNA NORAD upregulate SIP1 expression to promote cell proliferation and invasion in cervical cancer. Biomed Pharmacother 106:1454\u20131460","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"5855_CR35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12943-017-0738-0","volume":"16","author":"H Li","year":"2017","unstructured":"Li H, Wang X, Wen C, Huo Z, Wang W, Zhan Q et al (2017) Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer. Mol Cancer 16(1):169","journal-title":"Mol Cancer"},{"issue":"6","key":"5855_CR36","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.urolonc.2018.02.019","volume":"36","author":"Q Li","year":"2018","unstructured":"Li Q, Li C, Chen J, Liu P, Cui Y, Zhou X et al (2018) High expression of long noncoding RNA NORAD indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer. Urol Oncol 36(6):310 e15\u2013e22","journal-title":"Urol Oncol"},{"key":"5855_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.cca.2018.11.025","volume":"489","author":"Z Yang","year":"2019","unstructured":"Yang Z, Zhao Y, Lin G, Zhou X, Jiang X, Zhao H (2019) Noncoding RNA activated by DNA damage (NORAD): biologic function and mechanisms in human cancers. Clin Chim Acta 489:5\u20139","journal-title":"Clin Chim Acta"},{"issue":"1","key":"5855_CR38","first-page":"290","volume":"11","author":"H He","year":"2019","unstructured":"He H, Yang H, Liu D, Pei R (2019) LncRNA NORAD promotes thyroid carcinoma progression through targeting miR-202-5p. Am J Transl Res 11(1):290\u2013299","journal-title":"Am J Transl Res"},{"issue":"11","key":"5855_CR39","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.7150\/ijbs.59404","volume":"17","author":"R Wei","year":"2021","unstructured":"Wei R, Zhao Y, Wang J, Yang X, Li S, Wang Y et al (2021) Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells. Int J Biol Sci 17(11):2703\u20132717","journal-title":"Int J Biol Sci"},{"key":"5855_CR40","doi-asserted-by":"crossref","unstructured":"\u017dalyt\u0117 E (2023) Ferroptosis, metabolic rewiring, and endometrial cancer. Int J Mol Sci 25(1):75","DOI":"10.3390\/ijms25010075"},{"issue":"9","key":"5855_CR41","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen X, Li J, Kang R, Klionsky DJ, Tang D (2021) Ferroptosis: machinery and regulation. Autophagy 17(9):2054\u20132081","journal-title":"Autophagy"},{"issue":"4","key":"5855_CR42","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1007\/s10565-022-09751-z","volume":"39","author":"P Ruan","year":"2023","unstructured":"Ruan P, Wang S, Yang C, Huang X, Sun P, Tan A (2023) M(6)A mRNA methylation regulates the ERK\/NF-kappaB\/AKT signaling pathway through the PAPPA\/IGFBP4 axis to promote proliferation and tumor formation in endometrial cancer. Cell Biol Toxicol 39(4):1611\u20131626","journal-title":"Cell Biol Toxicol"},{"issue":"7","key":"5855_CR43","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.trecan.2022.02.010","volume":"8","author":"Y Li","year":"2022","unstructured":"Li Y, Su R, Deng X, Chen Y, Chen J (2022) FTO in cancer: functions, molecular mechanisms, and therapeutic implications. Trends Cancer 8(7):598\u2013614","journal-title":"Trends Cancer"},{"issue":"1","key":"5855_CR44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.canlet.2011.12.033","volume":"319","author":"Z Zhang","year":"2012","unstructured":"Zhang Z, Zhou D, Lai Y, Liu Y, Tao X, Wang Q et al (2012) Estrogen induces endometrial cancer cell proliferation and invasion by regulating the fat mass and obesity-associated gene via PI3K\/AKT and MAPK signaling pathways. Cancer Lett 319(1):89\u201397","journal-title":"Cancer Lett"},{"issue":"6","key":"5855_CR45","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.tcb.2019.02.008","volume":"29","author":"J Liu","year":"2019","unstructured":"Liu J, Harada BT, He C (2019) Regulation of gene expression by N(6)-methyladenosine in cancer. Trends Cell Biol 29(6):487\u2013499","journal-title":"Trends Cell Biol"},{"issue":"6","key":"5855_CR46","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1002\/hep.29683","volume":"67","author":"M Chen","year":"2018","unstructured":"Chen M, Wei L, Law CT, Tsang FH, Shen J, Cheng CL et al (2018) RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional Silencing of SOCS2. Hepatology 67(6):2254\u20132270","journal-title":"Hepatology"},{"issue":"1","key":"5855_CR47","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-020-00450-x","volume":"6","author":"X Jiang","year":"2021","unstructured":"Jiang X, Liu B, Nie Z, Duan L, Xiong Q, Jin Z et al (2021) The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther 6(1):74","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"5855_CR48","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12943-020-01220-7","volume":"19","author":"X Chen","year":"2020","unstructured":"Chen X, Xu M, Xu X, Zeng K, Liu X, Pan B et al (2020) METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer. Mol Cancer 19(1):106","journal-title":"Mol Cancer"},{"key":"5855_CR49","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210279","author":"S Ma","year":"2021","unstructured":"Ma S, Yan J, Barr T, Zhang J, Chen Z, Wang LS et al (2021) The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20210279","journal-title":"J Exp Med"},{"issue":"1","key":"5855_CR50","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13046-024-03032-9","volume":"43","author":"Y Qiao","year":"2024","unstructured":"Qiao Y, Su M, Zhao H, Liu H, Wang C, Dai X et al (2024) Targeting FTO induces colorectal cancer ferroptotic cell death by decreasing SLC7A11\/GPX4 expression. J Exp Clin Cancer Res 43(1):108","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"5855_CR51","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13020-023-00820-x","volume":"18","author":"F Wang","year":"2023","unstructured":"Wang F, Sun Z, Zhang Q, Yang H, Yang G, Yang Q et al (2023) Curdione induces ferroptosis mediated by m6A methylation via METTL14 and YTHDF2 in colorectal cancer. Chin Med 18(1):122","journal-title":"Chin Med"},{"issue":"1","key":"5855_CR52","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s13046-021-02096-1","volume":"40","author":"Y Cui","year":"2021","unstructured":"Cui Y, Zhang C, Ma S, Li Z, Wang W, Li Y et al (2021) RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma. J Exp Clin Cancer Res 40(1):294","journal-title":"J Exp Clin Cancer Res"},{"key":"5855_CR53","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jare.2021.10.001","volume":"37","author":"H Yang","year":"2022","unstructured":"Yang H, Hu Y, Weng M, Liu X, Wan P, Hu Y et al (2022) Hypoxia inducible lncRNA-CBSLR modulates ferroptosis through m6A-YTHDF2-dependent modulation of CBS in gastric cancer. J Adv Res 37:91\u2013106","journal-title":"J Adv Res"},{"issue":"8","key":"5855_CR54","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1080\/15548627.2023.2200554","volume":"19","author":"Q Xue","year":"2023","unstructured":"Xue Q, Kang R, Klionsky DJ, Tang D, Liu J, Chen X (2023) Copper metabolism in cell death and autophagy. Autophagy 19(8):2175\u20132195","journal-title":"Autophagy"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05855-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-025-05855-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-025-05855-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T11:03:29Z","timestamp":1761390209000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-025-05855-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,25]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5855"],"URL":"https:\/\/doi.org\/10.1007\/s00018-025-05855-x","relation":{},"ISSN":["1420-9071"],"issn-type":[{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,25]]},"assertion":[{"value":"26 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of The First Affiliated Hospital of USTC. All sample collection and data investigation procedures were conducted following the principles of the Declaration of Helsinki, with signed informed consent obtained from patients and their families. All animal experiments in this study were reviewed and ratified by the Animal Ethics Committee of The First Affiliated Hospital of USTC.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The work described has not been published previously, that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Submission declaration and verification"}}],"article-number":"364"}}